Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Surgical Oncology
|
May 22, 2019
A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment
Brian C Baumann, Robert A Lustig, Susan Mazzoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Hypoxia is important in the biology and aggression of human glial brain tumors
Sydney M Evans, Kevin D Judy, Isolde Dunphy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Prompt Gamma Imaging for In Vivo Range Verification of Pencil Beam Scanning Proton Therapy
Yunhe Xie, El Hassane Bentefour, Guillaume Janssens, et al.
Pediatric Blood & Cancer
|
May 4, 2026
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study
Jin-Ho Song, Jonathan Baron, Carlos Chavez Perez, et al.
Advances in Radiation Oncology
|
March 29, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas
Sana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, et al.
Scientific Reports
|
February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach
Jun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Scientific Reports
|
May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma
Anahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.
JCO Clinical Cancer Informatics
|
March 20, 2020
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
Anahita Fathi Kazerooni, Hamed Akbari, Gaurav Shukla, et al.
The Oncologist
|
February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy
Ian Messing, Lauren Linkowski, Matthew D Riina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Surgical Oncology
|
May 22, 2019
A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment
Brian C Baumann, Robert A Lustig, Susan Mazzoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Hypoxia is important in the biology and aggression of human glial brain tumors
Sydney M Evans, Kevin D Judy, Isolde Dunphy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Prompt Gamma Imaging for In Vivo Range Verification of Pencil Beam Scanning Proton Therapy
Yunhe Xie, El Hassane Bentefour, Guillaume Janssens, et al.
Pediatric Blood & Cancer
|
May 4, 2026
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study
Jin-Ho Song, Jonathan Baron, Carlos Chavez Perez, et al.
Advances in Radiation Oncology
|
March 29, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas
Sana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, et al.
Scientific Reports
|
February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach
Jun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Scientific Reports
|
May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma
Anahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.
JCO Clinical Cancer Informatics
|
March 20, 2020
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
Anahita Fathi Kazerooni, Hamed Akbari, Gaurav Shukla, et al.
The Oncologist
|
February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy
Ian Messing, Lauren Linkowski, Matthew D Riina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Page
of 6